SIGA Technologies, Inc. (NASDAQ:SIGA) Sees Large Decline in Short Interest

SIGA Technologies, Inc. (NASDAQ:SIGA) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 3,530,000 shares, a drop of 22.8% from the October 31st total of 4,570,000 shares. Currently, 8.7% of the company’s stock are sold short. Based on an average daily volume of 584,300 shares, the short-interest ratio is currently 6.0 days.

SIGA Technologies Price Performance

SIGA stock traded down $0.08 during mid-day trading on Friday, reaching $7.28. 274,299 shares of the company traded hands, compared to its average volume of 548,530. SIGA Technologies has a 52-week low of $4.26 and a 52-week high of $12.83. The company has a fifty day moving average price of $6.94 and a 200-day moving average price of $7.85. The company has a market capitalization of $519.79 million, a P/E ratio of 6.07 and a beta of 0.89.

SIGA Technologies (NASDAQ:SIGA) last posted its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The business had revenue of $10.01 million for the quarter. As a group, analysts forecast that SIGA Technologies will post 1.04 EPS for the current year.

Hedge Funds Weigh In On SIGA Technologies

Several institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in shares of SIGA Technologies by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock valued at $19,548,000 after acquiring an additional 41,515 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in SIGA Technologies by 996.5% in the first quarter. CANADA LIFE ASSURANCE Co now owns 24,836 shares of the company’s stock valued at $212,000 after purchasing an additional 22,571 shares during the last quarter. Lazard Asset Management LLC bought a new position in SIGA Technologies during the first quarter worth $105,000. Price T Rowe Associates Inc. MD boosted its position in shares of SIGA Technologies by 8.2% during the first quarter. Price T Rowe Associates Inc. MD now owns 29,180 shares of the company’s stock worth $250,000 after buying an additional 2,218 shares during the period. Finally, Bayesian Capital Management LP acquired a new stake in SIGA Technologies in the first quarter worth approximately $97,000. Hedge funds and other institutional investors own 55.40% of the company’s stock.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.